Clinical Research in Ocular Oncology
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Clinical Research of Cancer".
Deadline for manuscript submissions: 31 March 2026 | Viewed by 38
Special Issue Editors
2. Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA
Interests: ocular oncology
Interests: ocular oncology; uveal melanoma; retinoblastoma
Special Issues, Collections and Topics in MDPI journals
Interests: uveal melanoma; ophthalmology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This Special Issue will cover all aspects of clinical research in ocular oncology. Research related to all types of ophthalmic cancers is welcome: intraocular, periocular and orbital tumors, including both benign and malignant neoplasms. Authors are encouraged to consider submissions related to diagnosis, treatment, medical systems, and patient-reported outcomes/quality of life. We welcome original research articles, reviews, communications, and systematic reviews covering various aspects of clinical research in ophthalmic cancers.
Dr. Anthony Daniels
Dr. Arun D. Singh
Prof. Dr. Jens Folke Kiilgaard
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- ocular oncology
- eye cancer
- tumors
- melanoma
- retinoblastoma
- hemangioma
- hemangioblastoma
- lymphoma
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
